140 related articles for article (PubMed ID: 4124197)
1. Clinical evaluation of carcinoembryonic antigen test.
Meeker WR; Kashmiri R; Hunter L; Clapp W; Griffen WO
Arch Surg; 1973 Aug; 107(2):266-74. PubMed ID: 4124197
[No Abstract] [Full Text] [Related]
2. Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
McIntire KR; Waldmann TA; Go VL; Moertel CG; Ravry M
Ann Clin Lab Sci; 1974; 4(2):104-8. PubMed ID: 4819750
[No Abstract] [Full Text] [Related]
3. Immunologic diagnosis of human digestive tract cancer. Carcinoembryonic antigens.
Kamholz SL
Am J Gastroenterol; 1973 Mar; 59(3):233-43. PubMed ID: 4121819
[No Abstract] [Full Text] [Related]
4. Studies on carcinoembryonic and related antigens in malignant tumours of colon-rectum.
Orjasaeter H; Fredriksen G; Liavåg I
Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(4):599-608. PubMed ID: 4118734
[No Abstract] [Full Text] [Related]
5. Carcinoembryonic antigen (CEA). Use and limitations of the CEA radioimmunoassay in the diagnosis and follow-up of colo-rectal carcinoma.
Mach JP; Pusztaszeri G; MacDonald D; Bertholet MM
Johns Hopkins Med J Suppl; 1974; 3():369-79. PubMed ID: 4421371
[No Abstract] [Full Text] [Related]
6. Carcinoembryonic antigen (CEA): comparison of the Farr and solid-phase methods for detection of CEA.
McPherson TA; Band PR; Grace M; Hyde HA; Patwardhan VC
Int J Cancer; 1973 Jul; 12(1):42-54. PubMed ID: 4597862
[No Abstract] [Full Text] [Related]
7. [Ganglioside and carcinoembryonic antigens in the diagnosis of malignant tumors of the gastrointestinal tract].
Ivanov PK; Samoĭlenko VM
Vopr Onkol; 1984; 30(9):55-9. PubMed ID: 6495695
[TBL] [Abstract][Full Text] [Related]
8. Immunology and colonic cancer: further evaluation of the radioimmunoassay for carcinoembryonic antigen of the human digestive system as an adjunct in cancer diagnosis.
Gold P; Wilson T; Romero R; Shuster J; Freedman SO
Dis Colon Rectum; 1973; 16(5):358-65. PubMed ID: 4775052
[No Abstract] [Full Text] [Related]
9. Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.
Mennini G; Silecchia G; Zanna C; Cucchiara G; Spadaro G; Greco E; Basoli A; Speranza V
Ital J Surg Sci; 1985; 15(1):37-43. PubMed ID: 3858272
[TBL] [Abstract][Full Text] [Related]
10. Clinical aspects of the CEA test.
Laurence JR; Neville AM
Bull Cancer; 1976; 63(4):473-81. PubMed ID: 1021177
[No Abstract] [Full Text] [Related]
11. Clinical evaluation of the new tumor marker TAG-72.
Guadagni F; Roselli M; Ferroni P; Amato T; Colcher D; Greiner JW; Schlom J
Anticancer Res; 1991; 11(4):1389-94. PubMed ID: 1746895
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of carcinoembryonic antigen (CEA) plasma concentration in the 1st diagnosis of digestive-tract malignomas].
Auer IO; Münch L; Epping J; Schmid L
Z Gastroenterol; 1977 Aug; 15(8):491-503. PubMed ID: 906599
[No Abstract] [Full Text] [Related]
13. Tissue polypeptide antigen - a new tumour marker?
Wagner W; Husemann B; Becker H; Groitl H; Koerfgen HP; Hammerschmidt M
Aust N Z J Surg; 1982 Feb; 52(1):41-3. PubMed ID: 6951549
[No Abstract] [Full Text] [Related]
14. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
[No Abstract] [Full Text] [Related]
15. [Utility of CA19-9 and CEA as tumor marker in colorectal cancer--comparison between serum level and distribution].
Okuda K; Kodaira S; Watanabe M; Takami H; Teramoto T; Abe O; Iri H; Ino Y; Hirohashi S
Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):969-77. PubMed ID: 3463631
[No Abstract] [Full Text] [Related]
16. Fetal antigens in human digestive tumors.
Martin F; Martin MS; Bourgeaux C
Eur J Cancer (1965); 1976 Mar; 12(3):165-75. PubMed ID: 59668
[No Abstract] [Full Text] [Related]
17. Studies on tumor-associated antigen: TAA.
Gerfo PL; Herter FP; Volsi VL; Bennett S
J Surg Res; 1973 Oct; 15(4):290-5. PubMed ID: 4126473
[No Abstract] [Full Text] [Related]
18. [Experience in the use of the tumor markers CEA, GICA and TPA in the postoperative monitoring of colorectal neoplasms].
Morelli M; Nardi M; Valle M; Balducci D; Serafini D; Bernardini P
Minerva Med; 1985 Sep; 76(34-35):1529-31. PubMed ID: 2412188
[TBL] [Abstract][Full Text] [Related]
19. Preliminary immunologic characterization of glycoprotein antigens (CEA) of tumors of gastrointestinal tract in humans.
Harlozińska A; Zawadzka H; Woźniewski A; Richter R
Arch Immunol Ther Exp (Warsz); 1975; 23(2):247-55. PubMed ID: 50054
[TBL] [Abstract][Full Text] [Related]
20. [Radioimmunoassay of carcinoembryogenic antigen (CEA) in patients with carcinoma. Conclusion from preliminary results of a collaborative study in Switzerland].
Mach JP; Pusztaszeri G; Dysli M; Kapp F; Bierens de Haan B; Loosli RM; Grob P; Isliker H
Schweiz Med Wochenschr; 1973 Mar; 103(10):365-71. PubMed ID: 4120789
[No Abstract] [Full Text] [Related]
[Next] [New Search]
